BioDelivery Sciences signs deal with nonprofit group

01/26/2009 | Pharmaceutical Business Review Online

BioDelivery Sciences International has agreed to work with the nonprofit Drugs for Neglected Diseases initiative in testing the safety and efficacy of Bioral Amphotericin B, a treatment for leishmaniasis, Chagas' disease and other communicable diseases. Bioral Amphotericin B uses BDSI's patented Bioral drug delivery technology to allow the drug to be administered orally rather than intravenously.

View Full Article in:

Pharmaceutical Business Review Online

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA